The SAQ's listed below are a sample of the vast bank of questions developed by AFEM to allow preparation for the 2015.1 exams.
To access the password protected domains of the pre-course question bank - please register for the course. Attendance at the 4 day course will provide a simulated trial environment, individual & written feedback to candidates, curriculum revision and the full AFEM question bank of SAQ's.
To access the password protected domains of the pre-course question bank - please register for the course. Attendance at the 4 day course will provide a simulated trial environment, individual & written feedback to candidates, curriculum revision and the full AFEM question bank of SAQ's.
SAQ 3 - Respiratory
An Ambulance has brought in a 75 year old man with severe shortness of breath for the last 6 hrs. He is a heavy smoker with a history of COPD on regular Salbutamol nebulizers at home.
On arrival to ED, he looks distressed and diaphoretic with peripheral cyanosis.
His vital signs include:
HR 130 RR 40 BP 160/70 Temp 38.5C
His Arterial Blood Gas on 12 L O2 therapy:
PH 7.10 (7.35-7.45)
PO2 70 mmHg (80-95)
PCo2 92 mmHg (35-45)
HCo2 42 mmol (22-28)
O2 Sat 88%
Questions:
1- List 4 key abnormalities in the above gas and it’s clinical implications. (2)
2- List 3 bronchodilator agents, doses and 2 possible side effects for each drug that can be used in his treatment. (4)
3. Name 4 factors that you would assess when considering initiating BIPAP ventilation for this patient. Provide a short explanation for each. (4)
4- Despite your NIV trial, the patient has deteriorated further and requires endotracheal intubation and mechanical ventilation.
List 5 ventilation strategies for this patient (2.5)
[12.5 =12.5min]
On arrival to ED, he looks distressed and diaphoretic with peripheral cyanosis.
His vital signs include:
HR 130 RR 40 BP 160/70 Temp 38.5C
His Arterial Blood Gas on 12 L O2 therapy:
PH 7.10 (7.35-7.45)
PO2 70 mmHg (80-95)
PCo2 92 mmHg (35-45)
HCo2 42 mmol (22-28)
O2 Sat 88%
Questions:
1- List 4 key abnormalities in the above gas and it’s clinical implications. (2)
2- List 3 bronchodilator agents, doses and 2 possible side effects for each drug that can be used in his treatment. (4)
3. Name 4 factors that you would assess when considering initiating BIPAP ventilation for this patient. Provide a short explanation for each. (4)
4- Despite your NIV trial, the patient has deteriorated further and requires endotracheal intubation and mechanical ventilation.
List 5 ventilation strategies for this patient (2.5)
[12.5 =12.5min]